Quantum-Si Incorporated | Micro-cap | Healthcare
$1.14
-1.29%
| Quantum-Si Stock Comparison:
Quantum-Si vs Abbott LaboratoriesQuantum-Si vs Boston ScientificQuantum-Si vs Outset MedicalQuantum-Si vs CerusQuantum-Si vs 908 DevicesQuantum-Si vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 842.0K
Gross Profit 486.0K 57.72%
Operating Income -25.1M -2,982.42%
Net Income -19.2M -2,278.98%
EPS (Diluted) $-0.11

Balance Sheet Metrics

Total Assets 271.2M
Total Liabilities 24.3M
Shareholders Equity 246.9M
Debt to Equity 0.10

Cash Flow Metrics

Operating Cash Flow -17.0M
Free Cash Flow -27.5M

Revenue & Profitability Trend

Quantum-Si Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i3.1M1.1M000
Cost of Goods Sold i1.5M594.0K00-
Gross Profit i1.6M488.0K00-
Gross Margin % i52.3%45.1%0.0%0.0%0.0%
Operating Expenses
Research & Development i59.6M67.0M72.1M46.6M27.6M
Selling, General & Administrative i50.5M44.6M42.3M50.3M9.1M
Other Operating Expenses i-----
Total Operating Expenses i110.2M111.7M114.4M96.9M36.7M
Operating Income i-108.6M-111.2M-114.4M-96.9M-36.7M
Operating Margin % i-3,550.6%-10,274.6%0.0%0.0%0.0%
Non-Operating Items
Interest Income i-----
Interest Expense i-005.0K9.0K
Other Non-Operating Income7.6M15.2M-18.1M1.9M87.0K
Pre-tax Income i-101.0M-96.0M-132.4M-95.0M-36.6M
Income Tax i56.0K0000
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-101.0M-96.0M-132.4M-95.0M-36.6M
Net Margin % i-3,303.0%-8,868.8%0.0%0.0%0.0%
Key Metrics
EBITDA i-111.6M-106.6M-111.3M-95.8M-35.8M
EPS (Basic) i$-0.71$-0.68$-0.95$-1.19$-0.27
EPS (Diluted) i$-0.71$-0.68$-0.95$-1.19$-0.27
Basic Shares Outstanding i14319600014130000013925513179578540136400660
Diluted Shares Outstanding i14319600014130000013925513179578540136400660

Income Statement Trend

Quantum-Si Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i49.2M133.9M84.3M35.8M36.9M
Short-term Investments i160.4M123.9M267.0M435.5M0
Accounts Receivable i1.3M368.0K0--
Inventory i4.1M3.9M0--
Other Current Assets3.0M4.3M6.9M5.9M-
Total Current Assets i218.0M266.3M358.2M477.2M37.9M
Non-Current Assets
Property, Plant & Equipment i26.5M29.2M29.8M14.4M4.2M
Goodwill i0532.0K019.0M0
Intangible Assets i-532.0K---
Long-term Investments-----
Other Non-Current Assets808.0K695.0K697.0K690.0K738.0K
Total Non-Current Assets i29.9M31.9M33.3M26.1M2.7M
Total Assets i247.9M298.2M391.5M503.2M40.6M
Liabilities
Current Liabilities
Accounts Payable i1.9M1.8M3.9M3.4M1.3M
Short-term Debt i3.7M1.6M1.4M859.0K-
Current Portion of Long-term Debt-----
Other Current Liabilities514.0K194.0K88.0K23.0K68.0K
Total Current Liabilities i18.2M11.6M15.7M11.5M2.8M
Non-Current Liabilities
Long-term Debt i9.2M13.7M16.1M7.2M1.7M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities19.0K11.0K-206.0K-
Total Non-Current Liabilities i14.3M15.0M17.1M14.7M1.7M
Total Liabilities i32.5M26.6M32.8M26.2M4.5M
Equity
Common Stock i18.0K14.0K14.0K14.0K1.0K
Retained Earnings i-596.6M-495.6M-399.7M-267.2M-172.2M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i215.4M271.6M358.7M477.0M36.1M
Key Metrics
Total Debt i12.9M15.3M17.4M8.1M1.7M
Working Capital i199.8M254.7M342.5M465.6M35.1M

Balance Sheet Composition

Quantum-Si Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-101.0M-96.0M-132.4M-95.0M-36.6M
Depreciation & Amortization i4.6M4.2M2.6M1.0M894.0K
Stock-Based Compensation i8.9M8.5M11.2M24.9M1.9M
Working Capital Changes i136.0K-6.9M49.0K1.4M792.0K
Operating Cash Flow i-84.9M-89.2M-117.5M-67.1M-33.0M
Investing Activities
Capital Expenditures i-4.6M-4.5M-10.7M-5.8M-461.0K
Acquisitions i-00-4.6M0
Investment Purchases i-369.4M-123.8M-834.0K-440.5M0
Investment Sales i341.4M272.5M148.8M00
Investing Cash Flow i-32.6M144.2M137.2M-450.9M-461.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i--001.7M
Debt Repayment i-00-1.8M-57.0K
Financing Cash Flow i34.8M-208.0K-848.0K511.0M37.0M
Free Cash Flow i-92.4M-99.3M-101.3M-72.6M-33.0M
Net Change in Cash i-82.8M54.8M18.8M-7.1M3.5M

Cash Flow Trend

Quantum-Si Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -1.61
Forward P/E -1.44
Price to Book 0.95
Price to Sales 67.66
PEG Ratio -1.44

Profitability Ratios

Profit Margin 52.32%
Operating Margin -4,527.58%
Return on Equity -46.87%
Return on Assets -27.01%

Financial Health

Current Ratio 9.43
Debt to Equity 5.04
Beta 2.89

Per Share Data

EPS (TTM) $-0.67
Book Value per Share $1.20
Revenue per Share $0.02

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
qsi230.8M-1.610.95-46.87%52.32%5.04
Abbott Laboratories 228.6B16.484.5230.93%32.43%26.50
Boston Scientific 157.6B63.337.0311.55%13.55%53.09
Outset Medical 243.8M-0.371.61-87.65%-82.06%63.59
Cerus 250.2M-11.954.52-35.56%-9.81%176.07
908 Devices 232.8M-2.971.56-53.40%-28.13%2.98

Financial data is updated regularly. All figures are in the company's reporting currency.